Click here to go to the previous page
Chemistry, Manufacturing and Controls (CMC) Regulatory Landscape in Emerging Markets
Program Code:
116
Date:
Monday, June 24, 2013
Time:
11:00 AM to 12:30 PM
EST
CHAIR
:
Thirunellai G Venkateshwaran, PhD (SCHNON), Director Pharma Technical Regulatory, Genentech, A Member of the Roche Group, United States
SPEAKER
(S):
Chi-Wan Chen, PhD (SPKNON), Executive Director, Global CMC, Pfizer Inc, United States
Rebecca E. Komas,
MS (SPKNON), Director, CMC Advocacy,
GlaxoSmithKline, United States
Bekki E. Komas is Director of Chemistry, Manufacturing and Controls, Regulatory Affairs Advocacy and Intelligence at GlaxoSmithKline, Research Triangle Park, NC. She has been employed by GlaxoSmithKline for twenty seven years is currently Director of CMC Advocacy and Intelligence.
|
Sampat Singhvi, Millennium Pharmaceuticals, Inc., United States
Description
This session will discuss the challenges observed due to the changing regulations in emerging markets.